First American Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

First American Bank’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,470	Closed	-$204K	–	337
2017 Q3	$204K	Buy	+2,470	New	+$196K	0.02%	321
2015 Q3	–	Sell	-2,870	Closed	-$252K	–	257
2015 Q2	$252K	Hold	2,870	–	–	0.02%	218
2015 Q1	$213K	Buy	+2,870	New	+$203K	0.02%	232

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

First American Bank's CLVS Position: Q4 2017 in Review

First American Bank sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 2,470 shares — an estimated $204K sold.

First American Bank first reported a position in CLVS in Q1 2015 and held it in 3 quarters. The position peaked at $252K in Q2 2015. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

First American Bank reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
First American Bank sold 2,470 Clovis Oncology, Inc. shares in Q4 2017, an estimated $204K.
First American Bank first reported a position in Clovis Oncology, Inc. in Q1 2015 and held it in 3 quarters.
First American Bank's Clovis Oncology, Inc. position peaked at $252K in Q2 2015.
247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on First American Bank's 13F filing for Q4 2017, filed 23 Jan 2018.